394 related articles for article (PubMed ID: 29146177)
21. Clostridium sordellii genome analysis reveals plasmid localized toxin genes encoded within pathogenicity loci.
Couchman EC; Browne HP; Dunn M; Lawley TD; Songer JG; Hall V; Petrovska L; Vidor C; Awad M; Lyras D; Fairweather NF
BMC Genomics; 2015 May; 16(1):392. PubMed ID: 25981746
[TBL] [Abstract][Full Text] [Related]
22. Comparison of Clostridium sordellii toxins HT and LT with toxins A and B of C. difficile.
Martinez RD; Wilkins TD
J Med Microbiol; 1992 Jan; 36(1):30-6. PubMed ID: 1370542
[TBL] [Abstract][Full Text] [Related]
23. Activation of a c-Jun-NH2-terminal kinase pathway by the lethal toxin from Clostridium sordellii, TcsL-82, occurs independently of the toxin intrinsic enzymatic activity and facilitates small GTPase glucosylation.
Geny B; Popoff MR
Cell Microbiol; 2009 Jul; 11(7):1102-13. PubMed ID: 19341436
[TBL] [Abstract][Full Text] [Related]
24. The large clostridial toxins from Clostridium sordellii and C. difficile repress glucocorticoid receptor activity.
Tait AS; Dalton M; Geny B; D'Agnillo F; Popoff MR; Sternberg EM
Infect Immun; 2007 Aug; 75(8):3935-40. PubMed ID: 17517870
[TBL] [Abstract][Full Text] [Related]
25. Identification of a hemorrhagic determinant in
Zheng Y; Yang Q; Luo J; Zhang Y; Li X; He L; Ma C; Tao L
Microbiol Spectr; 2024 May; ():e0035424. PubMed ID: 38709085
[No Abstract] [Full Text] [Related]
26. Serogroup F strains of Clostridium difficile produce toxin B but not toxin A.
Depitre C; Delmee M; Avesani V; L'Haridon R; Roels A; Popoff M; Corthier G
J Med Microbiol; 1993 Jun; 38(6):434-41. PubMed ID: 8510136
[TBL] [Abstract][Full Text] [Related]
27. Non-toxigenic Clostridium sordellii: clinical and microbiological features of a case of cholangitis-associated bacteremia.
Walk ST; Jain R; Trivedi I; Grossman S; Newton DW; Thelen T; Hao Y; Songer JG; Carter GP; Lyras D; Young VB; Aronoff DM
Anaerobe; 2011 Oct; 17(5):252-6. PubMed ID: 21726656
[TBL] [Abstract][Full Text] [Related]
28. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
[TBL] [Abstract][Full Text] [Related]
29. Human peptide α-defensin-1 interferes with Clostridioides difficile toxins TcdA, TcdB, and CDT.
Fischer S; Ückert AK; Landenberger M; Papatheodorou P; Hoffmann-Richter C; Mittler AK; Ziener U; Hägele M; Schwan C; Müller M; Kleger A; Benz R; Popoff MR; Aktories K; Barth H
FASEB J; 2020 May; 34(5):6244-6261. PubMed ID: 32190927
[TBL] [Abstract][Full Text] [Related]
30. The Sialidase NanS Enhances Non-TcsL Mediated Cytotoxicity of Clostridium sordellii.
Awad MM; Singleton J; Lyras D
Toxins (Basel); 2016 Jun; 8(6):. PubMed ID: 27322322
[TBL] [Abstract][Full Text] [Related]
31. Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome.
Ng J; Hirota SA; Gross O; Li Y; Ulke-Lemee A; Potentier MS; Schenck LP; Vilaysane A; Seamone ME; Feng H; Armstrong GD; Tschopp J; Macdonald JA; Muruve DA; Beck PL
Gastroenterology; 2010 Aug; 139(2):542-52, 552.e1-3. PubMed ID: 20398664
[TBL] [Abstract][Full Text] [Related]
32. Structural dynamics of the CROPs domain control stability and toxicity of Paeniclostridium sordellii lethal toxin.
Zhou Y; Zhan X; Luo J; Li D; Zhou R; Zhang J; Pan Z; Zhang Y; Jia T; Zhang X; Li Y; Tao L
Nat Commun; 2023 Dec; 14(1):8426. PubMed ID: 38114525
[TBL] [Abstract][Full Text] [Related]
33. Functional implications of lethal toxin-catalysed glucosylation of (H/K/N)Ras and Rac1 in Clostridium sordellii-associated disease.
Genth H; Just I
Eur J Cell Biol; 2011 Nov; 90(11):959-65. PubMed ID: 21134703
[TBL] [Abstract][Full Text] [Related]
34. Antibodies against recombinant catalytic domain of lethal toxin of Clostridium sordellii neutralize lethal toxin toxicity in HeLa cells.
Arya P; Ponmariappan S; Singh L; Prasad GB
Protein Pept Lett; 2013 Feb; 20(2):205-12. PubMed ID: 22894159
[TBL] [Abstract][Full Text] [Related]
35. Killing of rat basophilic leukemia cells by lethal toxin from Clostridium sordellii: critical role of phosphatidylinositide 3'-OH kinase/Akt signaling.
Dreger SC; Schulz F; Huelsenbeck J; Gerhard R; Hofmann F; Just I; Genth H
Biochemistry; 2009 Mar; 48(8):1785-92. PubMed ID: 19199813
[TBL] [Abstract][Full Text] [Related]
36. Difference in protein substrate specificity between hemorrhagic toxin and lethal toxin from Clostridium sordellii.
Genth H; Hofmann F; Selzer J; Rex G; Aktories K; Just I
Biochem Biophys Res Commun; 1996 Dec; 229(2):370-4. PubMed ID: 8954906
[TBL] [Abstract][Full Text] [Related]
37. Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470.
Huelsenbeck J; Dreger S; Gerhard R; Barth H; Just I; Genth H
Infect Immun; 2007 Feb; 75(2):801-9. PubMed ID: 17145947
[TBL] [Abstract][Full Text] [Related]
38. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of immunological properties and cytotoxic effects of Clostridium difficile toxin B and Clostridium sordellii toxin L.
Baldacini O; Girardot R; Green GA; Rihn B; Monteil H
Toxicon; 1992 Feb; 30(2):129-40. PubMed ID: 1557784
[TBL] [Abstract][Full Text] [Related]
40. Reactive Oxygen Species as Additional Determinants for Cytotoxicity of Clostridium difficile Toxins A and B.
Frädrich C; Beer LA; Gerhard R
Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26797634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
